Journal of Antimicrobial Chemotherapy (2001) 47, 521-526
© 2001 The British Society for Antimicrobial Chemotherapy
Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates
a Departments of Clinical Microbiology and b Mycobacteriology, Statens Serum Institut, Artillerivej 5, DK-2300S, Copenhagen; c Department of Clinical Microbiology, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark
Three methods were compared for the susceptibility testing of yeast isolates to fluconazole and amphotericin B: two fagar diffusion methods (Etest and a tablet diffusion test) and the National Committee for Clinical Laboratory Standards (NCCLS) broth microdilution method. Given as MIC50s (range), fluconazole endpoints were: for the 24 h broth microdilution test, 0.25 mg/L (0.0632 mg/L); for the Etest, 0.38 mg/L (0.06424 mg/L); and for the NCCLS broth microdilution test, 2 mg/L (0.06
64 mg/L). With breakpoints of <3 mg/L for susceptible and >16 mg/L for resistant, the Etest and the 24 h microdilution test classified the isolates in agreement with the classification obtained by the NCCLS method. Results obtained by Etest were in closer NCCLS method than those obtained with the tablet test. Amphotericin B endpoints were lower for the 24 h microdilution and Etests than MICs obtained by the NCCLS broth microdilution method. Reproducibility was high for all tests; however, disadvantages of both diffusion tests were microcolonies in the inhibition zone and dependence on stringent standardization of inoculum.
* Corresponding author. Tel: +45-44-88-38-79; Fax: +45-44-88-37-72; E-mail: mad{at}ssi.dk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. J. Park, B. A. Arthington-Skaggs, R. A. Hajjeh, N. Iqbal, M. A. Ciblak, W. Lee-Yang, M. D. Hairston, M. Phelan, B. D. Plikaytis, A. N. Sofair, et al. Evaluation of Amphotericin B Interpretive Breakpoints for Candida Bloodstream Isolates by Correlation with Therapeutic Outcome Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1287 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Pfaller, D. J. Diekema, L. Boyken, S. A. Messer, S. Tendolkar, and R. J. Hollis Evaluation of the Etest and Disk Diffusion Methods for Determining Susceptibilities of 235 Bloodstream Isolates of Candida glabrata to Fluconazole and Voriconazole J. Clin. Microbiol., May 1, 2003; 41(5): 1875 - 1880. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Maxwell, S. A. Messer, R. J. Hollis, L. Boyken, S. Tendolkar, D. J. Diekema, and M. A. Pfaller Evaluation of Etest Method for Determining Fluconazole and Voriconazole MICs for 279 Clinical Isolates of Candida Species Infrequently Isolated from Blood J. Clin. Microbiol., March 1, 2003; 41(3): 1087 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Wolf, R. Falk, M. Hacham, B. Theelen, T. Boekhout, G. Scorzetti, M. Shapiro, C. Block, I. F. Salkin, and I. Polacheck Multidrug-Resistant Trichosporon asahii Infection of Nongranulocytopenic Patients in Three Intensive Care Units J. Clin. Microbiol., December 1, 2001; 39(12): 4420 - 4425. [Abstract] [Full Text] [PDF] |
||||

